{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:01:08Z","timestamp":1785898868491,"version":"3.56.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,9,17]],"date-time":"2017-09-17T00:00:00Z","timestamp":1505606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00520-017-3885-3","type":"journal-article","created":{"date-parts":[[2017,9,17]],"date-time":"2017-09-17T04:44:18Z","timestamp":1505623458000},"page":"751-758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy and safety of 153Sm-EDTMP as treatment of painful bone metastasis: a large single-center study"],"prefix":"10.1007","volume":"26","author":[{"given":"H\u00e9l\u00e8ne","family":"Kolesnikov-Gauthier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Tresch-Bruneel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Oudoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Penel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,17]]},"reference":[{"key":"3885_CR1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.semnuclmed.2009.10.003","volume":"40","author":"FM Paes","year":"2010","unstructured":"Paes FM, Serafni AN (2010) Systemic metabolic radiopharmaceutical therapy in the treatment of metastatic bone pain. Sem Nucl Med 40:89\u2013104","journal-title":"Sem Nucl Med"},{"key":"3885_CR2","first-page":"1358","volume":"45","author":"N Pandit-Taskar","year":"2004","unstructured":"Pandit-Taskar N, Batraki M, Divgi CR (2004) Radiopharmaceutical therapy for palliation of bone pain from osseous metastases. J Nucl Med 45:1358\u20131365","journal-title":"J Nucl Med"},{"key":"3885_CR3","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0959-8049(97)00155-X","volume":"33","author":"I Resche","year":"1997","unstructured":"Resche I, Chatal JF, Pecking A, Ell P, Duchesne G, Rubens R, Fogelman I, Houston S, Fauser A, Fischer M, Wilkins D (1997) A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer 33:1583\u20131591","journal-title":"Eur J Cancer"},{"key":"3885_CR4","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1200\/JCO.1998.16.4.1574","volume":"16","author":"AN Serafini","year":"1998","unstructured":"Serafini AN, Houston SJ, Resche I, Quick DP, Grund FM, Ell PJ, Bertrand A, Ahmann FR, Orihuela E, Reid RH, Lerski RA, Collier BD, McKillop JH, Purnell GL, Pecking AP, Thomas FD, Harrison KA (1998) Palliation of pain associated with metastatic bone cancer using samarium-153lexidronam: a double-blind placebo-controlled clinical trial. J Clin Oncol 16:1574\u20131581","journal-title":"J Clin Oncol"},{"key":"3885_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s002590050351","volume":"26","author":"JH Tian","year":"1999","unstructured":"Tian JH, Zhang JM, Hou QT, Oyang QH, Wang JM, Luan ZS, Chuan L, He YJ (1999) Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylenediaminetetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China. Eur J Nucl Med 26:2\u20137","journal-title":"Eur J Nucl Med"},{"key":"3885_CR6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/cncr.22431","volume":"109","author":"O Sartor","year":"2007","unstructured":"Sartor O, Reid RH, Bushnell DL, Quick DP, Ell AJ (2007) Safety and efficacy of repeat administration of samarium Sm-153 lexidronam to patients with metastatic bone pain. Cancer 109:637\u2013643","journal-title":"Cancer"},{"key":"3885_CR7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.arcmed.2014.03.006","volume":"45","author":"Correa-Gonzalez","year":"2014","unstructured":"Correa-Gonzalez, Arteaga de Murphy C, Pichardo-Romero P, Pedraza-Lopez M, Moreno-Garcia C, Correa-Hernandez L (2014) 153Sm-EDTMP for pain relief of bone metastases from prostate and breast cancer and other malignancies. Arch Med Res 45:301\u2013308","journal-title":"Arch Med Res"},{"key":"3885_CR8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4103\/0019-509X.25890","volume":"43","author":"M Tripathi","year":"2006","unstructured":"Tripathi M, Singhal T, Chandrasekhar N, Kumar P, Bal C, Jhulka PK, Bandopadhyaya G, Malhotra A (2006) Samarium-153 ethylediamine tretramethylene phosphonate therapy for bone pain palliation in skeletal metastases. Indian J Cancer 43:86\u201393","journal-title":"Indian J Cancer"},{"key":"3885_CR9","first-page":"193","volume":"160","author":"T Montesano","year":"2009","unstructured":"Montesano T, Giacomobono S, Acqualagna G, Colandrea M, Di Nicola A, Travascio L, Giancamerla M, D'Apollo R, Toteda M, Ugolini F, Filesi M, Ronga G (2009) Our experience on pain palliation of bone metastases with Sr-89 or Sm-153 in cancer patients resistant to a conventional analgesic therapy. A retrospective study. Clin Ter 160:193\u2013199","journal-title":"Clin Ter"},{"key":"3885_CR10","first-page":"1839","volume":"34","author":"C Collins","year":"1993","unstructured":"Collins C, Eary JF, Dnaldson G, Vernon C, Busch NE, Petersdorf S (1993) Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I\/II trial. J Nucl Med 34:1839\u20131844","journal-title":"J Nucl Med"},{"key":"3885_CR11","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.2967\/jnumed.115.155762","volume":"56","author":"P Thapa","year":"2015","unstructured":"Thapa P, Nikam D, Das T, Sonawane G, Agarwal JP, Basu S (2015) Clinical efficacy and safety comparison of 177Lu-EDTMP with 153Sm-SDTMP on an equidose basis in patients with painful skeletal metastases. J Nucl Med 56:1513\u20131519","journal-title":"J Nucl Med"},{"key":"3885_CR12","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/annonc\/mdn178","volume":"19","author":"DE Heron","year":"2008","unstructured":"Heron DE, Brufsky A, Beriwal S, Kurman M (2008) Myelotoxicity of samarium Sm 153 lexidronam in patients receiving prior treatment with chemotherapy or radiotherapy. Ann Oncol 19:1639\u20131643","journal-title":"Ann Oncol"},{"key":"3885_CR13","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1200\/JCO.2008.18.9811","volume":"27","author":"K Fizazi","year":"2009","unstructured":"Fizazi K, Beuzeboc P, Lumbroso J, Haddad V, Massard C, Gross-Goupil M, Di Palma M, Escudier B, Theodore C, Loriot Y, Tournay E, Bouzy J, Laplanche A (2009) Phase II trial of consolidation docetaxel and Samarium-153 in patients with bone metastases from castration-resistant prostate cancer. J Clin Oncol 27:2429\u20132435","journal-title":"J Clin Oncol"},{"key":"3885_CR14","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1200\/JCO.2008.20.5393","volume":"27","author":"SM Tu","year":"2009","unstructured":"Tu SM, Mathew P, Wong FC, Jones D, Johnson MM, Logothetis CJ (2009) Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer. J Clin Oncol 27:3319\u20133324","journal-title":"J Clin Oncol"},{"key":"3885_CR15","first-page":"79","volume":"43","author":"R Sciuto","year":"2002","unstructured":"Sciuto R, Festa A, Rea S, Pasqualoni R, Bergomi S, Pettrili G, Maini CL (2002) Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial. J Nucl Med 43:79\u201386","journal-title":"J Nucl Med"},{"key":"3885_CR16","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1002\/cncr.28103","volume":"119","author":"KA Autio","year":"2013","unstructured":"Autio KA, Pandit-Taskar N, Carrasquillo JA, Stephenson RD, Slovin SF, Rathkopft DE, Hong C, Heller G, Scher HI, Larson SM, Morris MJ (2013) Repetitively dosed docetaxel and 153Samarium-EDTMP as an antitumor strategy for metastatic castration-resistant prostate cancer. Cancer 119:3186\u20133194","journal-title":"Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-017-3885-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3885-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-017-3885-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,25]],"date-time":"2018-01-25T08:14:59Z","timestamp":1516868099000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-017-3885-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,17]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["3885"],"URL":"https:\/\/doi.org\/10.1007\/s00520-017-3885-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,17]]}}}